ICD9Data.com
  Free 2007 ICD-9-CM Database

2007 ICD-9-CM Procedure 99.25

Injection or infusion of cancer chemotherapeutic substance

  • A procedure in which the blood supply to the tumor is blocked surgically or mechanically and anticancer drugs are administered directly into the tumor. This permits a higher concentration of drug to be in contact with the tumor for a longer period of time.
  • 99.25 is a specific code that can be used to specify a procedure
  • 99.25 contains 16 index entries
  • View the full Volume 3 99.* hierarchy

99.25 also known as:

  • Chemoembolization
  • Injection or infusion of antineoplastic agent

99.25 excludes:

  • immunotherapy, antineoplastic (00.15, 99.28)
  • implantation of chemotherapeutic agent (00.10)
  • injection of radioisotope (92.28)
  • injection or infusion of biological response modifier [BRM] as an antineoplastic agent (99.28)

Index entries containing 99.25:

Chemoembolization 99.25
Chemotherapy - see also Immunotherapy
  • for cancer NEC 99.25
    • brain wafer implantation 00.10
    • implantation of chemotherapeutic agent 00.10
    • interstitial implantation 00.10
    • intracavitary implantation 00.10
    • wafer chemotherapy 00.10
Embolization (transcatheter)
  • chemoembolization 99.25
Infusion (intra-arterial) (intravenous)
  • antineoplastic agent (chemotherapeutic) 99.25
    • biological response modifier [BRM] 99.28
    • cintredekin besudotox 99.28
    • high-dose interleukin-2 00.15
    • low-dose interleukin-2 99.28
  • cancer chemotherapy agent NEC 99.25
Injection (into) (hypodermically) (intramuscularly) (intravenously) (acting locally or systemically)
  • Actinomycin D, for cancer chemotherapy 99.25
  • antineoplastic agent (chemotherapeutic) NEC 99.25
    • biological response modifier [BRM] 99.28
    • cintredekin besudotox 99.28
    • high-dose interleukin-2 00.15
    • low-dose interleukin-2 99.28
  • BCG
    • for chemotherapy 99.25
  • cancer chemotherapeutic agent 99.25
  • Methotrexate, for cancer chemotherapy 99.25
  • sclerosing agent NEC 99.29
    • treatment of malignancy (cytotoxic agent) 34.92 [99.25]
Perfusion NEC 39.97
  • for
    • chemotherapy NEC 99.25
Pleurodesis 34.6Pleurosclerosis 34.6ScarificationSclerotherapy